NOTICES
Notice No. 20230116-15 Notice Date 16 Jan 2023
Category Company related Segment Equity
Subject Listing of new securities of Sun Pharmaceutical Industries Ltd.
Content

Trading Members of the Exchange are hereby informed that the under mentioned new securities of Sun Pharmaceutical Industries Ltd. (Scrip Code: 524715) are listed and permitted to trade in with effect from Tuesday, January 17, 2023.<_o3a_p>

<_o3a_p><_o3a_p>

Securities<_o3a_p>

*330 Equity Shares of Re. 1/- each (pursuant to Bonus) kept in abeyance.<_o3a_p>

<_o3a_p><_o3a_p>

ISIN<_o3a_p>

INE044A01036<_o3a_p>

Distinctive Numbers<_o3a_p>

220<_o3a_p>

<_o3a_p><_o3a_p>

1042683137 to 1042683356<_o3a_p>

110<_o3a_p>

1042683397 to 1042683506<_o3a_p>

<_o3a_p><_o3a_p>

<_o3a_p>

*Please note that the entire 330 bonus equity shares are issued in physical form.<_o3a_p>

<_o3a_p><_o3a_p>

<_o3a_p>

<_o3a_p>

Sabah Vaze<_o3a_p>

Senior Manager<_o3a_p>

Attachments

Disclaimer

BSE Ltd. published this content on 16 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 January 2023 12:09:07 UTC.